N-(2-{[2,5-bis(2,2,2-trifluoroethoxy)phenyl]formamido}ethyl)acetamide

Catalog No. :
ACWLBM502
CAS No. :
338404-45-8
Molecular Formula :
C15H16F6N2O4
Molecular Weight :
402.29

IUPAC Name:N-(2-acetamidoethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide

N-(2-{[2,5-bis(2,2,2-trifluoroethoxy)phenyl]formamido}ethyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-{[2,5-bis(2,2,2-trifluoroethoxy)phenyl]formamido}ethyl)acetamide
IUPAC NameN-(2-acetamidoethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide
MDL No.MFCD00139601
Molecular FormulaC15H16F6N2O4
Molecular Weight402.29
SMILESCC(NCCNC(C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F)=O)=O
InChI KeyDUVKPIGIBOYKLI-UHFFFAOYSA-N
SynonymN-[2-(ACETYLAMINO)ETHYL]-2,5-BIS(2,2,2-TRIFLUOROETHOXY)BENZENECARBOXAMIDE;N-(2-{[2,5-bis(2,2,2-trifluoroethoxy)phenyl]formamido}ethyl)acetamide;Benzamide, N-[2-(acetylamino)ethyl]-2,5-bis(2,2,2-trifluoroethoxy)-
CAS No.338404-45-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACWLBM502 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLSDX695 route compound structure diagram
    ACLSDX6951001-53-2 In Stock
  2. Plus
  3. ACJCEU863 route compound structure diagram
    ACJCEU86335480-52-5 In Stock
  4. Then
  5. ACWLBM502 route product structure diagram
    ACWLBM502338404-45-8
Inquiry

2. ACWLBM502 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWLBM502 route product structure diagram
    ACWLBM502338404-45-8
Inquiry

Comments (0)